Citation Impact
Citing Papers
Advances and challenges in targeting FGFR signalling in cancer
2017
TGF-β signaling in fibrosis
2011 Standout
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
TGFβ signalling in context
2012 Standout
New Therapeutic Approaches to Mendelian Disorders
2010
Mechanotransduction and extracellular matrix homeostasis
2014 Standout
The pathogenesis of cardiac fibrosis
2013 Standout
Losartan Slows Pancreatic Tumor Progression and Extends Survival of SPARC-Null Mice by Abrogating Aberrant TGFβ Activation
2012
CD4+CD25+Foxp3+ regulatory T cells suppress cardiac fibrosis in the hypertensive heart
2011
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
2009
Inflammatory lipid mediators in adipocyte function and obesity
2010
Extracellular Microfibrils in Vertebrate Development and Disease Processes
2009
NF-κB, Inflammation, and Metabolic Disease
2011 Standout
Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy
2014 Standout
Cystic fibrosis genetics: from molecular understanding to clinical application
2014 Standout
Designing hydrogels for controlled drug delivery
2016 Standout
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology
2016 Standout
Lessons on the pathogenesis of aneurysm from heritable conditions
2011 Nature
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
MEK Inhibition in the Treatment of Advanced Melanoma
2013
Using sulfuramidimidoyl fluorides that undergo sulfur(vi) fluoride exchange for inverse drug discovery
2020 StandoutNobel
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
2020 Standout
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β
2010
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases
2011
Elastic fibres in health and disease
2013
Sustained Release of Engineered Stromal Cell–Derived Factor 1-α From Injectable Hydrogels Effectively Recruits Endothelial Progenitor Cells and Preserves Ventricular Function After Myocardial Infarction
2013
The paradoxical TGF-β vasculopathies
2012
Tocotrienols Reverse Cardiovascular, Metabolic and Liver Changes in High Carbohydrate, High Fat Diet-Fed Rats
2012
Tryptase/Protease-Activated Receptor 2 Interactions Induce Selective Mitogen-Activated Protein Kinase Signaling and Collagen Synthesis by Cardiac Fibroblasts
2011
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Matrix Metalloproteinases Promote Arterial Remodeling in Aging, Hypertension, and Atherosclerosis
2015
Marfan Syndrome and Related Disorders: 25 Years of Gene Discovery
2016
MLT-10 Defines a Family of DUF644 and Proline-rich Repeat Proteins Involved in the Molting Cycle ofCaenorhabditis elegans
2010 StandoutNobel
Abnormal muscle mechanosignaling triggers cardiomyopathy in mice with Marfan syndrome
2014
Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGF‐β expression and connective tissue features
2014
Inflammatory Mechanisms in Obesity
2011 Standout
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Works of David Loch being referenced
Arachidonic Acid Metabolism as a Potential Mediator of Cardiac Fibrosis Associated with Inflammation
2007
The N550K/H Mutations in FGFR2 Confer Differential Resistance to PD173074, Dovitinib, and Ponatinib ATP-Competitive Inhibitors
2013
Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN status
2012
p38 MAPK Is an Early Determinant of Promiscuous Smad2/3 Signaling in the Aortas of Fibrillin-1 (Fbn1)-null Mice
2008
Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble expoxide hydrolase
2007
Circulating Transforming Growth Factor-β in Marfan Syndrome
2009
Echocardiographic assessment of cardiac structure and function in rats
2002
Antifibrotic Activity of an Inhibitor of Group IIA Secretory Phospholipase A2 in Young Spontaneously Hypertensive Rats
2006
Angiotensin II–dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis
2013